New York Academy of Sciences launches angel investment network

StephenW

在中国，很少“天使”富有的投资者。但是，我们有很多HBVers. 从几个富有的投资者，比较容易募捐钱。从很多人更难收集, 但个人小投资风险小.

来自Nature Medicine http://www.nature.com/nm/journal/v17/n1/full/nm0111-4b.html

NEW YORK—New York City's burgeoning bioscience industry got a boost on 18 November when the New York Academy of Sciences launched a new network to connect private investors with fledgling life science companies looking for funding. The network, which is comprised of angel investors—wealthy individuals who risk their own money—will finance companies working to commercialize drugs, medical devices and other healthcare products. The goal is to bridge the funding gap between academic technology transfer offices and late-stage investors such as big corporations and venture capital firms.
To be eligible for funding, inventors must submit an application and business plan to the Life Science Angel Network's (LSAN) screening committee, a panel of scientists, physicians, venture capitalists and other technology development experts tasked with vetting proposals. The most promising applicants will have the opportunity to present their idea to the entire network.
纽约纽约市的新兴生物科学产业得到了提升，当11月18日，纽约科学院发起了一个新的网络，就可以与羽翼未丰的生命科学公司为寻找资金的私人投资者。该网络，这是天使投资人富裕的个人谁的风险由自己的钱，将财务公司致力于商业化药品，医疗器械和其他医疗产品。我们的目标是消除如大企业和风险投资公司之间的学术技术转移办公室和后期投资者的资金缺口。

为了获得资助，发明人必须提出申请，经营计划，生命科学天使网络的（LSAN）检查委员会，一个由科学家，医生，风险资本家和其他技术的开发，负责审查专家小组的建议。最有希望的申请者将有机会提出自己的想法到整个网络。